Roche’s Virtual Immunology/WCN Investor Event
Roche has hosted a virtual event on 7 February 2025
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Roche immunology kidney pipeline | Larry Tsai, Senior Vice President and Global Head of Product Development Immunology |
| Ph III (REGENCY) Gazyva in lupus nephritis data at WCN 2025 | Brad H. Rovin, MD, FASN, FACP |
| Q&A |
Webinar Replay
Investors